The objective ofthis article is to describe ourexperiences in treating patients for head and neck pilomatrixoma at our institution during a 5-year period and to compa re our f indings with previously published results. To that end, we conducted a 5-year retrospec tive cha rt review to identify those patients who had a confirmed histopath ologic dia gnosis ofp ilomatrixoma involving the head and neck area . We reviewed medical records for pr esentin g signs and symptoms, lesion cha racteristics, treatm ent rendered, and outcomes.
Introduction
Pilomatrixoma is a beni gn, usually asymptomatic neoplasm that arises from hair follicle matrix cells. It was originall y called a calcify ing ep ithelioma by Malherbe and Chen antais in their initial description in 1880. 1 In 1961, Forbi s and Helwig propo sed the current name to more accurately reflect the origin of the tumor. ' Affected individuals are typically young; peak incidence occ urs in patients 8 to 13 years of age. Its prevalence is slightly higher in white female s than in other groups.!? The lesion s usually appear as firm , solitary, From slowly grow ing, painless tumors of the dermis. They can extend into the subcutaneous tissues and often develop into encap sulated , irregular masses measuring between 0.5 and 5 em in diameter. The overl ying skin may exhibit a faint, blui sh-red discoloration on examination.v' The diagnosis can be confi rmed by histologic examin ation . Treatment consists of surgical excision. Recurrences are rare, but when they do occur, the physician should suspect a malignant pilomatrixoma variant.P Because most case descriptions are reported in the dermatology literatur e, otolaryngolo gists might not be familiar enou gh with the condition to include it in the differential diagnosis. The purpo se of this report is to desc ribe our experience with patients who were treated for a pilomatrixoma at our instituti on durin g a 5-ye ar period, and to comp are our findings with previou sly publi shed results. We discuss three specific cases, and we review the literature concernin g this neopla sm.
Materials and methods
We conducted a 5-year retrospective chart review to identify those patients who had been treated for pilomatrixoma at our institution between Jan . 1, 1992, and Jan . 1, 1997 . All patient medical records or operative reports that listed this as a final diagnosis were selected for detailed study. Patients whose lesions did not involve the head and neck region were excluded from further consideration. Medical records were carefully reviewed for presentin g signs and symptoms, lesion characteristics, treatment rendered, and outcomes for all patients who had a final histopath ologic diagnosis of pilomatrixoma of the head and neck area. We also examined histopathologic slides.
We also conducted a literature review to identify previously reported cases of pilomatrixoma that involved the head and neck region. Subject 
Results
A total of 56 patient s who had had a confirmed histologic diag nosis of piloma trixoma had undergone surgica l excision of their skin lesions at our institution within the designated time frame . Of this group, we identified 26 patients, aged 6 to 77 (mean: 33), whose pilomatrixoma had occurred in the head and neck regio n, and these 26 were selec ted for inclusion in this study. When noted in the medical record, mos t patients reported that their lesion had been present for at least 12 months before they sought treatment.
All 26 patients had been treated for solitary tum ors with simple surgical excision and clos ure. There were no reported adverse outco mes, although one patient had a histopathologic repor t of an incom plete excision. This patient had no evidence of recurrence 5 month s afte r treatment and has since been lost to followup . During their respective pos toperative periods, which ranged fro m 3 to 37 month s, no patient had a reported recurrence of tumor at the surgical site.
Three case studies illustrate the presentations of this type of neoplasm : Case 1. A I6-year-old boy was referred to the otolaryngology clinic for eva luation of a left preauricular mass that had been present for 18 months. The lesion, which had been progressively growi ng, was approxi mately 2 em in diameter. The patient repor ted no previous trauma to the area. On exa mination, various feat ures typical of a pilomatrixoma were present. The lesion was a subcutaneous nodule that was firm and irregular on palpation. The nodule was nontend er, and it was mobile over the deeper tissues in the preauricular area. A fain t, bluis h discoloration was noted through the overlyi ng skin. Following simple excision, histologic exami natio n confirmed the preoperative diagnosis.
Case 2. A I9-year-old woma n came to the otolaryngology clinic with a I-year history of a slow ly enlargi ng left facial mass. The swe lling was approxi mately 2 em in diameter at its widest point. The mass was mobile and lobul ated, and had a blu ish-red appearance. There were no palpable intraparotid masses, and all cran ial nerves were intact. The lesion was surg ically excised and sent for histologic evaluation. A pathology report agreed with the preoperative diagnosis of pilomatrixom a.
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Figure.
This neoplasm consists of pale, cornified cells whose nuclei have nearly disappeared; their outlines are visible only as shadows (small arrowheads) . This peculiar form of karyolysis earned these cells the designation "shadow cells." They are mature, neoplastic, matrical cells that have failed to develop into a hair. Instead, they act as foreign bodies and can cause a granulomatous foreign body reaction (large arrowhead).
(H&E stain x 100).
noted more than 2 years postoperatively.
Discussion
The head and neck region is the most common site of pilomatrixoma ; between 56 and 72% of all cases appear in this area .":" The next most common site is the upper extremities. Together, these two sites host the vast majority of these tumors.
Making a clinical diagnosis of pilomatrixoma can be difficult. The differential diagnoses include dermoid and inclusion cysts , preauricular sinuses, hemangiomas, and malignant softtissue tumors . Although many possibilities exist, the presence of such a nodule on the head , neck, or upper extremity, especially in a younger patient , should raise the clinician's suspicion of pilomatrixoma.
Fine-needle aspiration of these masses can yield cytologic results that are consistent with pilomatrixoma, although erroneous diagnoses of pilomatrixoma carcinoma have been reported. This exceedingly rare malignant variant of pilomatrixoma is histologically characterized by prominent nucleoli, focal areas of necrosis, and multiple mitotic figures. Even when they extend into subcutaneous tissues, pilomatrixomas typically remain well circumscribed. Histologic examination reveals polygonal basaloid cells with acidophilic cytoplasm and associated foci of calcification . Inflammatory cells as well as ghost, or shadow, cells formed by the keratinization of basaloid cells, are sometimes seen (figure). Evidence of vascular invasion and perineural or perichondrial infiltration support a diagnosis of a more aggressive type of pilomatrixoma that has the potential for malignant degeneration.V' -"
Various imaging methods for evaluating pilomatrixoma have been reported. Plain radiographs of suspicious lesions have limited utility, but they can detect foci of calcification." Preoperative radiographic imaging was not obtained for any of our patients. Computed tomography or magnetic resonance imaging might be considered for those patients who have larger or more unusual tumors . Ultrasonography has been described as a relatively fast and noninvasive investigative technique for estimating the depth of larger masses." The clinically superficial location of most of these tumors makes routine radiographic evaluation unnecessary. An accurate histopatho-546 logic evaluation is the most important tool for confirming the diagnosis.
Of the 56 patients who had been treated for pilomatrixoma at our institution during the 5-year study period, 26 (46%) had lesions that invol ved the face, a rate that is consistent with previously reported studies. Tumors were most often located in the neck (hair border), scalp , and eyebrow. Only three tumors (1 1:5%) involved the preauricular area and only three involved the forehead. These two areas have been reported to be common sites of pilomatrixoma, even though they do not feature a particularly high density of hair follicles . Considering the embryology of this neoplasm, it has been theorized that its etiology might be related to specific type s of hair."
As a group , our series of patients did not manifest the "typical" presentation variables (table) . For example, only 10 of our patients (38 %) were younger than 20, and only 8 (31%) were female. This pattern is easily explained by the fact that our institution is a military medical center, and most patients who are treated there are adult military service members and military retirees.
Depending on the site of involvement, the surgical approach can be modified to ensure the total removal of the lesion without injury to vital neural or vascular structures . For example, a modified Blair incision was used to remove the preauricular tumors of three patients in this series. Their preoperative assessments were consistent 
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With our design you no longer have to be a contortionist to access the anatomy. Our microscissors bring "tactile" touch back to your fingertips again. Plus, our ergonomic, in-line design is more comfortable and provides you with a superior control, eliminates "galloping" when actuating the blades. with small, superficial neopl asms that were eas ily removed and did not req uire facia l ner ve dissection. Co mplete surg ica l exc ision of the tum or is the recommended treatment, although Morales and McGoey reported that they successfully treated eig ht patients with incision and curett age of large lesion s on expos ed sites. IS Follo wing excision, pilom atrixom a recurrence s are relatively rare, with an overa ll rate of 2.6 % in a large series of patients." Our tre atm ent population rem ained free of recurrence dur ing foll owup periods that ranged fro m 3 to 37 month s. In the eve nt that a lesion does recur, the ph ysician sho uld suspec t pilomatri xorna carci noma.v':" Th e biologic activi ty of this malignant varia nt is similar to that of basal cell carcinom a, and agg ressive surgical exc ision re mains the recommended treatm ent of choice.
In con clusion, the res ults of our pa tie nt series suppo rt simple surg ica l exc ision as the treatm ent of choice for these tu mors. 
